Braster S.A. - Asset Resilience Ratio
Braster S.A. (BRA) has an Asset Resilience Ratio of 0.01% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Braster S.A. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2019)
This chart shows how Braster S.A.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Braster S.A. (BRA) total assets.
Liquid Assets Composition Over Time
This chart breaks down Braster S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Braster S.A.'s assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 0% |
| Short-term Investments | zł2.00K | 0.01% |
| Total Liquid Assets | zł2.00K | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Braster S.A. maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Braster S.A. Industry Peers by Asset Resilience Ratio
Compare Braster S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Braster S.A. (2019–2019)
The table below shows the annual Asset Resilience Ratio data for Braster S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-12-31 | 0.33% | zł163.00K ≈ $44.86K |
zł48.87 Million ≈ $13.45 Million |
-- |
About Braster S.A.
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more